EFFECT OF CHRONIC TREATMENT WITH 8-OH-DPAT IN THE FORCED SWIMMING TEST REQUIRES THE INTEGRITY OF PRESYNAPTIC SEROTONERGIC MECHANISMS

被引:44
作者
CERVO, L [1 ]
SAMANIN, R [1 ]
机构
[1] MARIO NEGRI INST PHARMACOL RES,VIA ERITREA 62,I-20157 MILAN,ITALY
关键词
SEROTONIN-1A RECEPTOR; ANTIDEPRESSANT ACTIVITY; DORSAL RAPHE NUCLEUS; 8-OH-DPAT; RAT;
D O I
10.1007/BF02244253
中图分类号
Q189 [神经科学];
学科分类号
071006 [神经生物学];
摘要
The effect of chronic treatment with 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) on rats' behaviour in the forced swimming test was studied in animals injected intracerebroventricularly with 150-mu-g 5,7-dihydroxytryptamine (5,7-DHT) or given three oral doses of parachlorophenylalanine (PCPA). A single dose of 0.25 mg/kg 8-OH-DPAT significantly reduced rats' immobility in 5,7-DHT-sham-operated animals 24 h after a 14-day schedule of 0.25 mg/kg 8-OH-DPAT or saline subcutaneously twice daily. The effects of acute 8-OH-DPAT in both chronically 8-OH-DPAT- and saline-treated animals were prevented by 5,7-DHT which caused a marked depletion of brain serotonin (5-HT). Since animals treated with both 8-OH-DPAT and 5,7-DHT were more active in an open field than those receiving the substances separately, the forced swimming behaviour was analyzed in more detail in subsequent experiments. PCPA treatment completely prevented the increase in struggling caused by acute and chronic 8-OH-DPAT, administered as in the previous experiment, but did not modify the reduction of floating caused by 8-oh-DPAT. PCPA and 8-OH-DPAT, alone or in combination, did not modify rats' activity in an open field. Finally, 0.5 and 1.0-mu-g 8-OH-DPAT in the nucleus raphe dorsalis significantly increased struggling and reduced floating to the same extent in animals which had received 0.25 mg/kg 8-OH-DPAT or saline subcutaneously twice daily for 14 days. It thus appears that the antidepressant-like effects of chronic treatment with 8-OH-DPAT in the forced swimming test require the integrity of presynaptic serotonergic mechanisms.
引用
收藏
页码:524 / 528
页数:5
相关论文
共 20 条
[1]
FORCED SWIMMING TEST IN RATS - EFFECT OF DESIPRAMINE ADMINISTRATION AND THE PERIOD OF EXPOSURE TO THE TEST ON STRUGGLING BEHAVIOR, SWIMMING, IMMOBILITY AND DEFECATION RATE [J].
ARMARIO, A ;
GAVALDA, A ;
MARTI, O .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 158 (03) :207-212
[2]
Baumgarten H G, 1973, Acta Physiol Scand Suppl, V391, P1
[3]
MODIFICATION OF 5-HT NEURON PROPERTIES BY SUSTAINED ADMINISTRATION OF THE 5-HT1A AGONIST GEPIRONE - ELECTROPHYSIOLOGICAL STUDIES IN THE RAT-BRAIN [J].
BLIER, P ;
DEMONTIGNY, C .
SYNAPSE, 1987, 1 (05) :470-480
[4]
DISCOVERY OF ANTIDEPRESSANT ACTIVITY BY FORCED SWIMMING TEST MAY DEPEND ON PRE-EXPOSURE OF RATS TO A STRESSFUL SITUATION [J].
BORSINI, F ;
LECCI, A ;
SESSAREGO, A ;
FRASSINE, R ;
MELI, A .
PSYCHOPHARMACOLOGY, 1989, 97 (02) :183-188
[5]
BEHAVIORAL AND BIOCHEMICAL INTERACTIONS OF 5,7-DIHYDROXYTRYPTAMINE WITH VARIOUS DRUGS WHEN ADMINISTERED INTRACISTERNALLY TO ADULT AND DEVELOPING RATS [J].
BREESE, GR ;
COOPER, BR .
BRAIN RESEARCH, 1975, 98 (03) :517-527
[6]
POTENTIAL ANTIDEPRESSANT PROPERTIES OF 8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN, A SELECTIVE SEROTONIN-1A RECEPTOR AGONIST [J].
CERVO, L ;
SAMANIN, R .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1987, 144 (02) :223-229
[7]
8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN, A SELECTIVE SEROTONIN1A RECEPTOR AGONIST, REDUCES THE IMMOBILITY OF RATS IN THE FORCED SWIMMING TEST BY ACTING ON THE NUCLEUS RAPHE DORSALIS [J].
CERVO, L ;
GRIGNASCHI, G ;
SAMANIN, R .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 158 (1-2) :53-59
[8]
CSANALOSI I, 1987, J CLIN PSYCHOPHARM, V7, P31
[9]
THE 5-HT1A RECEPTOR AGONIST, 8-OH-DPAT, PREFERENTIALLY ACTIVATES CELL BODY 5-HT AUTORECEPTORS IN RAT-BRAIN INVIVO [J].
HJORTH, S ;
MAGNUSSON, T .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1988, 338 (05) :463-471
[10]
EFFECT OF L-CYSTEINE ON THE LONG-TERM DEPLETION OF BRAIN INDOLES CAUSED BY P-CHLOROAMPHETAMINE AND D-FENFLURAMINE IN RATS - RELATION TO BRAIN DRUG CONCENTRATIONS [J].
INVERNIZZI, R ;
FRACASSO, C ;
CACCIA, S ;
DICLEMENTE, A ;
GARATTINI, S ;
SAMANIN, R .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 163 (01) :77-83